BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/27/2017 12:23:13 AM | Browse: 1133 | Download: 1407
 |
Received |
|
2017-06-16 02:14 |
|
Peer-Review Started |
|
2017-06-19 01:26 |
|
To Make the First Decision |
|
2017-07-10 00:46 |
|
Return for Revision |
|
2017-07-20 06:52 |
|
Revised |
|
2017-08-03 18:29 |
|
Second Decision |
|
2017-09-08 01:20 |
|
Accepted by Journal Editor-in-Chief |
|
2017-09-08 10:07 |
|
Accepted by Executive Editor-in-Chief |
|
2017-09-17 04:33 |
|
Articles in Press |
|
2017-09-17 04:33 |
 |
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2017-09-27 22:17 |
|
Typeset the Manuscript |
|
2017-10-25 01:51 |
|
Publish the Manuscript Online |
|
2017-10-27 00:23 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Marco Fiore, Alberto Enrico Maraolo, Ivan Gentile, Guglielmo Borgia, Sebastiano Leone, Pasquale Sansone, Maria Beatrice Passavanti, Caterina Aurilio and Maria Caterina Pace |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Marco Fiore, MD, Department of Anesthesiological, Surgical and Emergency Sciences, University of Campania “Luigi Vanvitelli”, Piazza Miraglia 2, Naples 80138, Italy. marco.fiore@unicampania.it |
| Key Words |
Spontaneous bacterial peritonitis; Multi-drug resistant bacteria; End-stage liver disease; Cirrhosis; Critically ill patient |
| Core Tip |
Spontaneous bacterial peritonitis (SBP) is the most common infection in end-stage liver disease cirrhotic patients. Over the last decade, a worryingly increasing prevalence of Gram-positive and multi-drug resistant (MDR) SBP causative bacteria has been seen. Numerous driving factors have been proposed as associated with this epidemiological change. The aim of this review is to describe, with an epidemiological focus, the evidence behind this rise in Gram-positive and MDR SBP from 2000 to present, and illustrate potential targeted therapeutic strategies. Third-generation cephalosporins should be avoided in clinical settings with a high prevalence of MDR. An appropriate treatment protocol should include daptomycin plus ceftaroline and meropenem. |
| Publish Date |
2017-10-27 00:23 |
| Citation |
Fiore M, Maraolo AE, Gentile I, Borgia G, Leone S, Sansone P, Passavanti MB, Aurilio C, Pace MC. Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis. World J Hepatol 2017; 9(30): 1166-1175 |
| URL |
http://www.wjgnet.com/1948-5182/full/v9/i30/1166.htm |
| DOI |
http://dx.doi.org/10.4254/wjh.v9.i30.1166 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
